HOME
 Acute Myelogenous
 Leukemia (AML)
 Other Leukemia Types
 (ALL / CLL / CML / HCL)
 Myelodysplastic Syndrome
 Symptoms and Diagnosis
 Leukemia Treatment Options
  " Chemotherapy
  " Blood Stem Cell Transplants
  " Radiation and Surgery
  " Chemo Side Effects
  " Clinical Trials Info
  " Coping with Leukemia
  " What to Ask Your Doctor
 Financial Assistance
 At Risk Jobs/Exposure
 Leukemia Resources
 Survivor's Story
 Leukemia News

 Search for information:
 
      Match:
any search words
all search words

Click Here for a Free
Information Packet

FOR MORE INFORMATION
Please call
1-800-923-6376

We will gladly answer your
questions and send a free
packet with additional
information on:

  • New treatment options
  • New clinical trials
  • Doctors
  • Hazardous jobs and products
  • Medical Financial Aid

 





 
Acute myelogenous leukemia picture

 Blood Cancer &
 Leukemia

Medical information about cancer

  Leukemia Cancer Information

Leukemia symptoms

Leukemia Cancer News - Return to Menu

CEPSA invests in new refining and petrochemical projects

11/16/2004 - Italy - These projects will entail total capital expenditures of over 300 million euros and the creation of nearly 100 direct jobs CEPSA plans to build a new Light Naphtha Reformer unit at its La Rábida Refinery

Production capacity at its petrochemical affiliate ERTISA will be raised by 60%

CEPSA will spend over 300 million euros to build a Light Naphtha Reformer (LNR) unit at its La Rábida Refinery and expand the facilities of its wholly-owned petrochemical affiliate ERTISA.

Construction of the Light Naphtha Reformer (LNR) unit at the La Rábida Refinery will require capital expenditures of 160 million euros. The plant will employ 25 workers, contributing to the consolidation of 700 direct jobs and other indirect employment generated by the Refinery and will afford greater added value to its productive processes.

The Light Naphtha Reforming unit will deploy AROMAX® technology, patented by Chevron Phillips Chemical Company, which will provide consulting and support services to CEPSA during the design and construction process of the plant, slated to be completed in the second half of 2006, around the same time as work to expand ERTISA will also be finalized.

The new facility will produce 220,000 tons per year of benzene and 75 tons per day of hydrogen, in addition to other products.

This project will make a new source available for the production of hydrogen, an essential component for obtaining a lower content of sulfur in fuels, pursuant to European Union environmental specifications, and allow new developments in this line. The increase in benzene production will reduce CEPSA's current shortage for its key applications (cyclohexane, phenol and linear alkylbenzene) and cover the needs of ERTISA's new plant.

In ERTISA, planned investments amount to 145 million euros, which will be assigned towards building a new Cumene/Phenol plant in order to meet growing demand for its products, especially for the manufacture of polycarbonate, a high-quality engineering plastic widely used in the audio/video and automotive industries.

Once construction work is completed, the plant will generate over 60 new jobs. At present, ERTISA directly employs 290 people.

ERTISA's new facility will consist of a Cumene unit, with a capacity of 300,000 tons per year, and a Phenol/Acetone unit, with capacities of 200,000 and 125,000 tons per year, respectively. As a result of this expansion, ERTISA will become the second leading European phenol producer and maintain its level of competitiveness from the integration of its processes with those of the La Rábida Refinery.

The petrochemical feedstocks produced by ERTISA are earmarked towards the manufacture of products such as special plastics, synthetic fibers, polycarbonates and metacrylates, to name a few. These components are sold at home and in a variety of countries and markets abroad, such as France, Germany, the Netherlands, Great Britain, Portugal, Belgium, North America and the Far East.

As a result of these projects, the company's refining/petrochemicals synergies will be enhanced considerably. In addition to its facilities in Spain, CEPSA also has petrochemical plants in Canada and Brazil and markets its products on all five continents around the globe.

LA RÁBIDA REFINERY 
 
 
 
Product  Current  LNR plant capacity   Total  
  capacity    capacity 
       
Benzene  141,000 MT/year  220,000 MT/year  361,000 MT/year 
Hydrogen  90 MT/day  75 MT/day  165 MT/day 

ERTISA 
 
 
 
Product  Current capacity  Increase in capacity MT/year  Total  
  MT/year    capacity 
       
Cumene  500,000  300,000  800,000 
Phenol  350,000  200,000  550,000 
Acetone  215,000  125,000  340,000 

Madrid, November 16, 2004

Institutional Relations Division

Tel: (34) 91 337 63 56

www.cepsa.com

© CompanynewsGroup



AML Leukemia News Archives
January February March April May June
July August September October November December


To Obtain the Best Treatment Info & Financial Assistance contact us for a FREE INFORMATION PACKET which includes:

Cancer Hospital Locations
Clinical Trials
Hazardous Jobs/ Products
New Treatment Options
Doctors
Financial Assistance

Fill out the form below or call 1-800-923-6376.

First Name
Last Name
Address
City
State
Zip

Phone

Email
   
Have you or a loved one been diagnosed or have:
   
Acute Myelogenous
Leukemia (AML)?
Yes  No
Myelodysplastic Syndrome (MDS)?

Yes  No
Aplastic Anemia?

Yes  No
Non-Hodgkin Lymphoma (NHL)?
Yes  No
Any other Leukemia
or Blood Disease?
( In the comment section below please state the diagnosis)

Yes  No
Did you or your loved one ever work around benzene?
Display At Risk Jobs / Exposure
Yes  No

How old is the patient?

 
   

Comment/
Info Request 

 

 

Site Map | Acute Myelogenous Leukemia

 

 



Medical Site Optimization by Nielsen Technical Services